Connect with us

National

The San: Zimbabwe’s forgotten tribe living on the margins

Published

on

BY JEFFREY MOYO

Nyaliwe Mendisi has never known the door of a classroom.

Advertisement

None of her 12 children went to school, and now the 81-year-old’s grandchildren and great-grandchildren have had no basic education either.

Mendisi belongs to the San community, together with her unschooled grandchildren and great-grandchildren.

Now stung with poverty, the only jobs her children and grandchildren have known are domestic employment in the villages of Tsholotsho, in Matabeleland North Province.

Advertisement

Most of her grandsons and granddaughters are employed as cattle herders or tend other villagers’ fields.

“My whole generation in my family has never been to school. We have nothing of value that we own to enable children to attend school. We have no goats nor cattle that we can sell to raise school fees,” Mendisi told Anadolu Agency.

Also known as the Bushmen or Basarwa, the San, which is Mendisi’s tribe, were the first Bantu people to dwell in present-day Zimbabwe.

Advertisement

Mired in poverty, many San people like Mendisi and her descendants, populate remote areas of this southern African nation, with others facing similar situations in other countries like Angola, Botswana, Namibia, South Africa, and Zambia.

In Zimbabwe, some of the apparently forgotten tribe lives in Plumtree in Matabeleland South Province.

Now, as the World commemorates International Day of the World’s Indigenous People annually on Aug. 9 by the UN, Zimbabwe’s Khoisans, like Mendisi, have nothing to celebrate amid mounting penury.

Advertisement

“Food is even hard to get because this region always gets very low rainfall. We have no cattle nor donkeys that we can use for our farming,” she said.

But what worries many like Mendisi and her family is the lack of national identity cards, which means together with her descendants, they have contended with statelessness.

“Having no IDs or birth certificates has meant none of us gets the opportunity to go to school or even dream of having a bank account,” Mlungisi Mendisi (23), a grandson on the matriarch, told Anadolu Agency.

Advertisement

Even decent shelter for the San tribe is something that they can only fathom in their imaginations, according to the younger Mendisi, who also said he has never had a bus ride or boarded a car.

With incessant droughts pounding Zimbabweans more often, the San have not been spared but getting food donations from the government has remained a mountain task for many like Mlungisi without identity documents.

“No ID no food from the government and some of us just have to starve. It has never been easy for many of us to get identity documents like birth certificates and national identity cards,” he said.

Advertisement

Davy Ndlovu, programmes manager for Tsoro-O-Tso San, a development trust that fosters the rights of the San tribe, said the minority tribe has for centuries faced broad injustices, leading to poverty situations for generations.

“Since the San’s removal from their ancestral land to pave way for the establishment of the Hwange National Park in 1928, their lives as hunter-gatherers were disrupted.

“Today, they live lives of poverty in the outer edges of society and are struggling to adapt to a sedentary lifestyle,” Ndlovu told Anadolu Agency.

Advertisement

To Ndlovu, like many minority groups in Zimbabwe, the Khoisan people are not strangers to segregation.

“Many minorities in Zimbabwe suffer discrimination and the situation is even worse for the San,” he said.

According to Tsoro-O-Tso San, there are approximately 2,500 San people living in Zimbabwe.

Advertisement

Even as Ndlovu and his organization have tried to help many Khoisan to enroll in school, families like Mendisi’s have had no chance.

But organizations like Tsoro-O-Tso San headed by Ndlovu, have tried to extricate many of Khoisan descendants from poverty.

“When we started our project in 2010, few of the San children finished primary education. After numerous awareness campaigns on the importance of education, quite a number has gone up to form four, with others even finishing form six of their secondary education,” said Ndlovu.

Advertisement

To Ndlovu, even as the Khoisan tribe remains downtrodden and apparently forgotten by authorities, there is something to smile about.

“For the first time ever, we have three Khoisan descendants attending university.

There is however little support from the government and this has left many San children uneducated,” said Ndlovu.

Advertisement

Health-wise, Ndlovu said the Khoisan are faced with trouble as health facilities are still few and people are forced to travel long distances to seek medical attention.

Ndlovu said with many San people still stateless here, several, like Christopher Dube of Garia village in Tsholotsho, have recently battled to bury an undocumented relative who died in neighbouring South Africa, also without personal documents.

According to Ndlovu, the deceased is still unburied in South Africa due to a lack of proper documentation. – Anadolu Agency.

Advertisement

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

National

Tragic attack in Madlambuzi: Five dead as suspected mental patient goes on rampage

Published

on

BY WANDILE TSHUMA 

Police in Madlambuzi, Matabeleland South Province has are a suspected mental patient, Phamani Sibanda, following a violent rampage that left five people dead and two others injured on Wednesday.

According to the police statement, Sibanda (43) allegedly attacked seven people in the village using a Mopani log, a blunt object, and an unknown sharp weapon, targeting anyone who crossed his path.

The victims of this tragic attack have been identified by their next of kin:

Elliot Khupe, 101, a male adult from Bellas Village
Butho Tshuma, 97, a female adult from Bellas Village
Constance Sibanda, 66, a female adult from Bellas Village
Tiffan Surprise Ndlovu, 6, a female juvenile from Bellas Village
Catra Matsika, 72, from Central Village

In addition to the fatalities, two other women, aged 90 and 41, sustained injuries and are currently receiving treatment at Madlambuzi Clinic and Plumtree District Hospital.

The ZRP has underscored the pressing need for community awareness regarding mental health issues. “We implore the public to promptly refer mental patients to medical institutions for treatment and to actively monitor their behavior to prevent such violent incidents,” the statement elaborated. It encouraged community members to report any concerns to the National Complaints Desk at (0242) 703631 or via WhatsApp at 0712 800197, or to approach the nearest police station.

 

Continue Reading

National

US suspends visa processing in Zimbabwe, embassy says

Published

on

BY REUTERS

The United States has stopped processing most visas in Zimbabwe until further notice, its embassy in the capital Harare said on Wednesday, citing unspecified concerns with the government.
“We have paused routine visa services in Harare while we address concerns with the Government of Zimbabwe,” the embassy said in a post on X. It said the move was not a travel ban and that current visas would remain valid.
The government of the Southern African country did not immediately reply to a request for comment.
The pause took effect on August 7, according to a notice on the U.S. State Department’s website, which said it applied to all visa services with the exception of most diplomatic and official visas.
U.S. President Donald Trump’s administration has restricted travel from a number of African countries, saying it is working to prevent visa overstaying and misuse.
Zimbabwe had a visa overstay rate of 10.57% in 2023, according to a U.S. Department of Homeland Security report.
Starting this week, the U.S. will require visa applicants from Zambia and Malawi to pay bonds of up to $15,000 for some visitor visas. The Trump administration has also paused visa processing in Niger.
Harare resident Angella Chirombo said her 18-year-old son had received a scholarship to do his bachelor’s degree at Michigan State University and had been waiting for a visa interview when the pause hit.
“He was supposed to be in school already. I paid for everything else and was waiting for the visa so I could buy tickets,” she told Reuters.
She said other parents were considering booking interviews at other U.S. embassies in Southern Africa, but that she wouldn’t be able to afford the travel.
“Now they are saying we can go to Zambia and Namibia. I don’t even have money right now and I don’t know where to get this money. They are so many students that have been affected.”

Continue Reading

National

Landmark HIV trial begins in Zimbabwe

Published

on


BY PAUL SIXPENCE

ZIMBABWE became the first site for the administration of a new investigational HIV vaccine. The first doses of the IAVI C114 clinical trial were administered in late July 2025 at the Mutala Trust clinical site in Harare, CITE reports.
“This is a landmark moment for South Africa, Zimbabwe, and the continent. It shows the power of true partnership,” said Dr. Tariro Makadzange, clinical trial lead, Mutala Trust.

“We are edging closer to an HIV vaccine, made possible by global collaboration, with clinical trials conducted in Africa, for Africa, and for the world.”

The development of the vaccine is a partnership that brings together Zimbabwe’s Mutala Trust, ReiThera, the Ragon Institute, International AIDS Vaccine Initiative (IAVI) and African researchers who are co-leading every phase of the trial.

In phase one of the trial, the vaccine candidate, Gorilla Adenovirus Vectored HIV Networked Epitopes Vaccine (GRAdHIVNE1) will be administered to 120 adults between the ages of 18 and 50 years including 48 people living with HIV who are virally suppressed on antiretroviral therapy (ART). Besides Zimbabwe, two other clinical trial sites are located in Cape Town and Durban, South Africa.

Trial sites were chosen on the basis of their high HIV burden and to ensure that the vaccine candidate is tested within communities affected by the epidemic.

This phase of the trial will assess the safety and ability of the vaccine candidate to provoke an immune response in the human body in persons living with HIV and those who are HIV negative.

“The IAVI C114 trial is testing a new vaccine candidate known as GRAdHIVNE1. The trial represents the first time this vaccine is being tested in humans and is aimed at assessing the safety of the vaccine and its ability to stimulate the immune system,” said Dr. Vincent Muturi-Kioi, HIV Vaccines Product Development Team Lead, IAVI.

In a statement, IAVI further advised that “trial participants will receive either one or two doses of the investigational vaccine or a placebo and will be monitored over a period of 19 months for safety and immune responses.” Results of the trial are likely to be available in 2027.

In the past, several HIV vaccine trials have been conducted but none proved effective in preventing HIV acquisition. The novelity of this vaccine candidate lies in that, it uses a harmless viral vector to deliver small parts of HIV “derived from critical structural regions of HIV that are less likely to mutate” with an expected likelihood to trigger an immune response.

“GRAdHIVNE1 uses a harmless virus (a vector for the vaccine derived from a non-replicating gorilla adenovirus) to deliver small, conserved parts of HIV (called epitopes) to the body’s immune system. These targets are derived from critical structural regions of HIV that are less likely to mutate, making them good targets for killer T cells in the immune system (CD8+ T cell responses) — a type of immune defense thought to be important for long-term protection against HIV. The viral vector was selected based on its ability to stimulate this type of response. Should the vaccine be successful in stimulating the desired response, it could be tested in future trials to assess its efficacy,” Dr. Vincent Muturi-Kioi further explained.

The initiation of this clinical trial demonstrates the power of partnerships at a time when the world is witnessing funding cuts towards global public health research. The IAVIC114 clinical trial is sponsored by IAVI. The vaccine candidate, GRAdHIVNE1, was developed by ReiThera and the Ragon Institute with funding from the GatesFoundation. African researchers will be leading

SOURCE| CITE

Advertisement



Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage